中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2008年
2期
184-185
,共2页
任建华%陈中腾%林正佳%陈宁
任建華%陳中騰%林正佳%陳寧
임건화%진중등%림정가%진저
多脏器功能障碍综合征%APACHE--评分
多髒器功能障礙綜閤徵%APACHE--評分
다장기공능장애종합정%APACHE--평분
Multiple organ dysfunction syndrome%Acute physiology and chronic health evaluation scores
目的 研究急性生理功能与慢性健康状况评分(APACHEⅡ和APACHEⅢ)对多脏器功能障碍综合征(MODS)预后评价的作用.方法 通过对45例MODS患者的回顾研究,分析存活组和死亡组MODS的APACHEⅡ和APACHEⅢ、脏器衰竭发生率及数量与MODS危重程度和预后之间关系.结果:存活组与死亡组MODS患者的APACHE Ⅱ、APACHEⅢ、年龄及脏器衰竭数之间差异有统计学意义(P<0.05),APACHEⅡ对脏器衰竭数和MODS的死亡率预测相关性较差(P>0.05),而APACHEⅢ有显著相关性(P<0.05).结论 APACHEⅢ对MODS的危重程度和预后的评估明显优于APACHE Ⅱ.
目的 研究急性生理功能與慢性健康狀況評分(APACHEⅡ和APACHEⅢ)對多髒器功能障礙綜閤徵(MODS)預後評價的作用.方法 通過對45例MODS患者的迴顧研究,分析存活組和死亡組MODS的APACHEⅡ和APACHEⅢ、髒器衰竭髮生率及數量與MODS危重程度和預後之間關繫.結果:存活組與死亡組MODS患者的APACHE Ⅱ、APACHEⅢ、年齡及髒器衰竭數之間差異有統計學意義(P<0.05),APACHEⅡ對髒器衰竭數和MODS的死亡率預測相關性較差(P>0.05),而APACHEⅢ有顯著相關性(P<0.05).結論 APACHEⅢ對MODS的危重程度和預後的評估明顯優于APACHE Ⅱ.
목적 연구급성생리공능여만성건강상황평분(APACHEⅡ화APACHEⅢ)대다장기공능장애종합정(MODS)예후평개적작용.방법 통과대45례MODS환자적회고연구,분석존활조화사망조MODS적APACHEⅡ화APACHEⅢ、장기쇠갈발생솔급수량여MODS위중정도화예후지간관계.결과:존활조여사망조MODS환자적APACHE Ⅱ、APACHEⅢ、년령급장기쇠갈수지간차이유통계학의의(P<0.05),APACHEⅡ대장기쇠갈수화MODS적사망솔예측상관성교차(P>0.05),이APACHEⅢ유현저상관성(P<0.05).결론 APACHEⅢ대MODS적위중정도화예후적평고명현우우APACHE Ⅱ.
objective To investigate the effect of the prognosis of multiple organ dysfunction syndrome(MODs) through APACHE Ⅱ and APACHE Ⅲ.Methods The relations of APACHEⅡ,APACHEⅢ,the occurrence rate and number of organs failure and the dangerous extent and prognosis of MODS are studied between survival group and death group through the review research of 45 cases of MODS.Results APACHE Ⅱ andⅢ,age and genrating rate of failure organS are significant difference between surviral group and death group(P<0.05)in MODS.The predicting correlation of APACHE Ⅱis not significant difference between number of organs failure and mortality of MODS(P>O.05),but the predicting correlation of APACHE Ⅲ is significant difference between number of organs failure and mortality of MODS(P<0.05).Conclusion The study showed APACHEⅢis better than APACHEⅡ on the dangerous extent and prognostic evaluation in MODS.